68-88-2
中文名称
2-[2-[4-[(4-氯苯基)-苯甲基]哌嗪-1-基]乙氧基]乙醇
英文名称
Hydroxyzine
CAS
68-88-2
分子式
C21H27ClN2O2
MDL 编号
MFCD00242772
分子量
374.904
MOL 文件
68-88-2.mol
68-88-2 结构式
基本信息
中文别名
羟嗪2-[2-[4-[(4-氯苯基)-苯甲基]哌嗪-1-基]乙氧基]乙醇
英文别名
1-(p-Chloro-alpha-phenylbenzyl)-4-(2-((2-hydroxyethoxy)ethyl)piperazine1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)diethylenediamine
1-(p-Chlorobenzhydryl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine
1-(p-Chlorodiphenylmethyl)-4-(2-(2-hydroxyethoxy)ethyl)piperazine
2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol
2-(2-(4-[(4-Chlorophenyl)(phenyl)methyl]-1-piperazinyl)ethoxy)ethanol
Atara
Atarax
Atarax base
Ataraxoid
Atarazoid
Atarox
Atazina
Aterax
Deinait
Equipoise
Ethanol, 2-[2-[4-(p-chloro-alpha-phenylbenzyl)-1-piperazinyl]ethoxy]-
Ethanol, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-
Hychotine
Hydroksyzyny
所属类别
原料药：抗焦虑药物理化学性质
熔点190°C
沸点250 °C(Press: 0.1 Torr)
密度1.1020 (rough estimate)
折射率1.5400 (estimate)
储存条件Sealed in dry,2-8°C
溶解度可溶于氯仿（少量）、DMSO（少量）、乙醇（少量）、甲醇（少量）
酸度系数(pKa)pKa 1.96± 0.05；7.40± 0.03(H2O,t =24.5±0.5)(Approximate)
形态油状至凝胶状
颜色无色至黄色
水溶解性< 700 mg/mL
BCS Class2
NIST化学物质信息Hydroxyzine base(68-88-2)
羟嗪价格(试剂级)
| 报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
| 2025/02/08 | HY-B0548 | 羟嗪 Hydroxyzine | 68-88-2 | 5 mg | 156元 |
| 2025/02/08 | HY-B0548 | 羟嗪 Hydroxyzine | 68-88-2 | 10 mg | 211元 |
| 2025/02/08 | HY-B0548 | 羟嗪 Hydroxyzine | 68-88-2 | 25 mg | 324元 |
常见问题列表
生物活性
Hydroxyzine，一种苯二氮卓抗组胺剂 (antihistamine)，作为口服活性组胺 H1 受体 (histamine H1-receptor) 和血清素拮抗剂。Hydroxyzine 具有抗焦虑作用，可用于广泛性焦虑障碍的研究。靶点
|
H 1 Receptor
|
体外研究
Hydroxyzine dihydrochloride inhibits carbachol (10 μM)-induced serotonin release by 34% at 10 μM, by 25% 1 μM and by 17% 0.1 μM in pretreated bladder slices for 60 min.
体内研究
Hydroxyzine dihydrochloride (12.5 mg/kg, 25 mg/kg and 50 mg/kg i.p.) shows little direct analgesic activity but markedly potentiates only the effect of morphine on the vocalization after-discharge which represents the affective component of pain in rats. Hydroxyzine dihydrochloride (50 mg/kg i.p.) potentiates morphine on the tail-flick test, while Hydroxyzine (12.5 mg/kg i.p.) decreases morphine antinociception in rats.